Skip to main content
    M

    MDxHealth SA (MDXH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.66
    +0.06 (+9.29%)

    Market Cap: $62.98M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    23%(5/22)
    Avg Surprise
    -53.77%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.09
    Range$-0.11 - $-0.06
    5 analysts
    EPS RevisionsNo revisions (7d)
    5
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.16+43.2%
    60d ago$-0.16+43.2%
    30d ago$-0.16+43.2%
    7d ago$-0.09-2.2%
    Current$-0.09
    Revenue Consensus
    $25M
    Range$23M - $25M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.02
    Range$-0.02 - $-0.02
    1 analysts
    Revenue Consensus
    $23M
    Range$21M - $25M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.02---
    Sep 26EST
    		-$-0.09---
    Jun 26
    Reported Aug 13
    		$-0.18$-0.12-50.00%Miss-28.6%
    Mar 26
    Reported May 13
    		$-0.17$-0.15-13.33%Miss+10.5%
    Dec 25
    Reported Feb 26
    		$-0.17$-0.13-30.77%Miss-21.4%
    Sep 25
    Reported Nov 12
    		$-0.16$-0.11-45.45%Miss+60.0%
    Jun 25
    Reported Aug 14
    		$-0.14$-0.12-16.67%Miss+54.8%
    Mar 25
    Reported May 14
    		$-0.19$-0.13-46.15%Miss+38.7%
    Dec 24
    Reported Feb 26
    		$-0.14$-0.19+26.32%Beat+64.1%
    Sep 24
    Reported Nov 6
    		$-0.40$-0.25-60.00%Miss+0.0%
    Jun 24
    Reported Aug 21
    		$-0.31$-0.26-19.23%Miss-3.3%
    Mar 24
    Reported May 1
    		$-0.31$-0.30-3.33%Miss+38.0%
    Dec 23
    Reported Mar 6
    		$-0.39$-0.25-56.00%Miss+64.5%
    Sep 23
    Reported Nov 7
    		$-0.40$-0.19-110.53%Miss+20.0%
    Jun 23
    Reported Aug 23
    		$-0.30$-0.22-36.36%Miss+57.1%
    Mar 23
    Reported May 15
    		$-0.50$-0.40-25.00%Miss+0.0%
    Dec 22
    Reported Mar 9
    		$-1.10$-0.65-69.23%Miss-25.0%
    Sep 22
    Reported Oct 27
    		$-0.50$-0.53+5.66%Beat+88.9%
    Jun 22
    Reported Aug 25
    		$-0.70$-0.60-16.67%Miss-1066.7%
    Mar 22
    Reported Apr 27
    		$-0.50$-0.53+5.66%Beat-733.3%
    Dec 21
    Reported Mar 2
    		$-0.88$-0.47-87.23%Miss-961.5%
    Sep 21
    Reported Nov 5
    		$-4.50$-0.60-650.00%Miss-650.0%
    Mar 21
    Reported Jun 30
    		$-0.06$0.00N/AMiss+33.3%
    Dec 20
    Reported Mar 3
    		$-0.06$0.00N/AMiss+33.3%
    Sep 20
    Reported Dec 31
    		$-0.08$0.00N/AMiss+62.1%
    Jun 20
    Reported Sep 29
    		$-0.60N/A+62.50%Beat-174.5%
    Mar 20
    Reported Jun 30
    		$-0.09$0.00N/AMiss+25.0%
    Dec 19
    Reported Mar 31
    		$-0.09$0.00N/AMiss+25.0%
    Sep 19
    Reported Dec 31
    		$-0.22$0.00N/AMiss-49.4%
    Jun 19
    Reported Sep 30
    		$-0.22$0.00N/AMiss+72.7%
    Mar 19
    Reported Jun 30
    		$-0.12$0.00N/AMiss+11.1%
    Dec 18
    Reported Mar 31
    		$-0.12$0.00N/AMiss+11.1%
    Sep 18
    Reported Dec 31
    		$-0.15$0.00N/AMiss-12.1%
    Jun 18
    Reported Aug 30
    		$-0.80N/A+52.94%Beat-513.0%
    Mar 18
    Reported Jun 30
    		$-0.14$0.00N/AMiss-2800.0%
    Dec 17
    Reported Mar 31
    		$-0.14$0.00N/AMiss-2800.0%
    Sep 17
    Reported Dec 31
    		$-0.13$0.00N/AMiss-
    Jun 17
    Reported Sep 30
    		$-0.13$0.00N/AMiss-
    Mar 17
    Reported Jun 30
    		$0.01$0.00N/ABeat-
    Dec 16
    Reported Mar 31
    		$0.01$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.97EV/EBITDAN/A
    Price/FCF-9.01xFCF Yield-11.10%
    Profitability
    Profit Margin-32.70%Operating Margin-18.70%
    ROE-2440.00%ROIC-40.55%
    Financial Health
    Debt/Equity-3.23xInterest Coverage-0.99x
    Current Ratio1.15xQuick Ratio0.98x
    Trading Statistics
    Beta-518287.38Avg Volume214.04K
    52-Week High$5.3352-Week Low$0.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.60
    SMA 20$0.60
    SMA 50$0.63
    SMA 200$1.73
    EMA 10$0.60
    EMA 20$0.61
    EMA 50$0.64
    EMA 200$1.41

    MACD

    Line: -0.01Signal: -0.02Hist: 0.01

    ADX

    ADX: 19.2+DI: 27.9-DI: 15.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down60.0
    PSAR$0.54

    Bollinger Bands

    Upper Band$0.68
    Lower Band$0.52
    %B Position2608%(Upper)
    Band Width0.90

    RSI (14-Day)

    Neutral
    58.4

    Momentum Oscillators

    Stoch %K74.2
    Stoch %D61.6
    Williams %R-6.6
    ROC (10d)26.9%
    Momentum0.14
    CCI (20d)107.3
    MFI (14d)52.2

    Volatility Measures

    ATR (14d)$0.05(6.9%)
    StdDev (20d)0.04
    Hist Vol73.5%(High)

    Volume Flow

    VWAP$0.64
    OBV298.4M
    AD Line-74.2M
    CMF (20d)-0.167

    Volume Metrics

    Avg Vol (20d)224.5K
    Vol Ratio2.2x(High)
    VWMA (20d)$0.60

    Pivot Points

    R3$0.65
    R2$0.63
    R1$0.62
    Pivot Point$0.60
    S1$0.59
    S2$0.57
    S3$0.55

    Advanced Oscillators

    TSI-6.48
    Ultimate Osc58.7
    KST-114.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$27.21M$54.66M$54.66M$27.43M$26.61M$24.29M$48.06M$23.32M$41.99M$19.83M$38.75M$19.35M
    Cost of Revenue$9.32M$25.36M$25.36M$9.56M$9.04M$8.79M$18.26M$9.04M$16.64M$7.77M$13.52M$6.80M
    Gross Profit$17.89M$29.31M$29.31M$17.88M$17.57M$15.50M$29.79M$14.28M$25.35M$12.06M$25.22M$12.55M
    Operating Expenses$22.99M$40.88M$40.88M$20.52M$19.48M$20.09M$40.49M$20.37M$39.37M$18.67M$36.09M$17.11M
    R&D$2.00M$10.35M$10.35M$2.01M$2.57M$2.50M$5.49M$2.70M$5.07M$2.16M$1.02M$1.56M
    SG&A$8.19M$39.44M$39.44M$7.46M$6.24M$5.84M$11.60M$5.74M$11.20M$5.36M$40.02M$5.38M
    Operating Income$-5,099,000$-11,569,000$-11,569,000$-2,642,000$-1,916,000$-4,588,000$-10,700,000$-6,092,000$-14,022,000$-6,604,000$-10,867,000$-4,561,000
    Interest Income$1.70M$7.38M$127,000$502,000$420,000$692,000$694,000$197,000$0$1.37M$0$564,000
    Interest Expense$6.08M$8.38M$8.38M$5.88M$6.29M$5.18M$7.14M$4.96M$4.66M$3.28M$10.46M$6.05M
    Income Before Tax$-9,478,000$-19,800,000$-19,800,000$-8,016,000$-7,788,000$-9,072,000$-17,648,000$-10,855,000$-20,039,000$-8,511,000$-20,764,000$-10,045,000
    Income Tax Expense$0$-1,025,000$-1,025,000$-6,000$-416,000$137,000$382,000$334,000$0$1,000$1,000$1.90M
    Net Income$-11,532,000$-18,775,000$-18,775,000$-8,010,000$-7,372,000$-9,209,000$-18,030,000$-11,189,000$-20,039,000$-8,511,000$-20,765,000$-10,045,000
    EBITDA$-1,006,000$-6,893,000$-6,740,000$680,000$770,000$-1,649,000$-6,162,000$-3,747,000$-8,953,000$-3,333,000$-17,046,000$-2,132,000
    EBIT$-3,398,000$-11,569,000$-11,416,000$-2,140,000$-1,496,000$-3,896,000$-10,503,000$-5,895,000$-12,651,000$-5,233,000$-20,493,000$-3,997,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MDXH

    Government Contracts

    Gov Obligations (TTM)
    $875172
    Gov Obligations / Revenue
    0.8%
    Obligations YoY
    N/A
    Active Awards
    12
    New Awards (TTM)
    6
    Avg Remaining Term
    6.2 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25726N0262Department of Veterans AffairsDepartment of Veterans Affairs$319293May 1, 2026
    36C25926N0080Department of Veterans AffairsDepartment of Veterans Affairs$243669Oct 1, 2025
    36C24826N0634Department of Veterans AffairsDepartment of Veterans Affairs$62668Jul 10, 2026
    36C25726N0313Department of Veterans AffairsDepartment of Veterans Affairs$27658Apr 3, 2026
    36C25726N0254Department of Veterans AffairsDepartment of Veterans Affairs$15965Jun 5, 2026
    36C25726N0052Department of Veterans AffairsDepartment of Veterans Affairs$0Jan 10, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Revenue fell short at MDxHealth (MDXH), prompting suspension of its 2026 revenue guidance.

    MDxHealth (MDXH) announced preliminary unaudited third-quarter 2026 revenue of approximately $22.7 million, matching the prior year...

    Stock Titan•10/16/26•Bearish

    Form 13D/A MDxHealth SA For: 16 October By Investing.com

    This article reports on the filing of Form 13D/A by MDxHealth SA on October 16. It includes current stock market data for MDxHealth (MDXH), showing a significant decline...

    Investing.com UK•10/16/26•Neutral

    MDxHealth Q3FY27 Results: Revenue flat at $22.7M, guidance suspended

    MDxHealth reported flat preliminary Q3FY27 revenue of $22.7 million, leading to the suspension of its full-year 2026 revenue guidance. The company attributed this shortfall to unexpected sales force turnover following...

    scanx.trade•10/16/26•Bearish

    MDxHealth SA (O6C1.SG) cash flow

    This article provides a detailed cash flow statement for MDxHealth SA (O6C1.SG) in USD, covering annual and quarterly data up to 2025. It breaks down operating, investing, and financing cash flows...

    Yahoo Finance Australia•10/15/26•Somewhat-Bearish

    MDxHealth misses Q3 revenue target, suspends 2026 guidance By Investing.com

    MDxHealth SA reported preliminary Q3 revenue of $22.7 million, missing its target and leading to the suspension of its full-year 2026 revenue guidance of $110-115 million. The company cited unexpected sales force...

    Investing.com India•10/15/26•Bearish

    MDXH Valuation and Fair Value

    P/E
    -1.0x
    Forward P/E
    27.7x
    P/FCF
    -9.0x
    P/B
    -1.1x
    See GNG's fair value

    MDXH Profitability: Margins, ROIC and FCF

    Gross margin
    57.6%
    Operating margin
    -18.7%
    Net margin
    -32.7%
    ROIC
    -40.5%
    ROE
    -2440.0%
    FCF margin
    -2.3%
    FCF yield
    -11.1%

    MDXH Competitors

    CompanyTicker
    ImmunoPrecise Antibodies Ltd.HYFT
    ZEN Graphene Solutions LtdZTEK
    OS Therapies IncorporatedOSTX
    Tenax Therapeutics IncTENX
    Rein Therapeutics IncRNTX
    Daxor CorporationDXR
    Verrica Pharmaceuticals IncVRCA
    Gain Therapeutics IncGANX

    Sector: Healthcare

    MDXH Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    0
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    0

    MDXH Bull Case vs Bear Case

    Bull case

    • 66.7% of MDXH's analyst ratings are Buy or Strong Buy.

    Bear case

    • MDXH has a -32.7% net profit margin.
    • MDXH beat EPS estimates in 12.5% of its last 8 reported quarters.

    MDXH Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -29.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.09
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    5 up, 0 down

    Frequently Asked Questions About MDXH

    Does MDXH pay dividends?

    MDxHealth SA (MDXH) does not currently pay a regular dividend.

    What is MDXH's market cap?

    MDxHealth SA (MDXH) has a market capitalization of $62.98M with a current stock price of $0.66.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In